LEPU ScienTech Medical Technology (Shanghai) Full Year 2022 Earnings: CN¥0.06 loss per share (vs CN¥0.19 profit in FY 2021)

LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) Full Year 2022 Results

Key Financial Results

• Revenue: CN¥247.7m (up 11% from FY 2021).
• Net loss: CN¥19.8m (down by 134% from CN¥58.7m profit in FY 2021).
• CN¥0.06 loss per share (down from CN¥0.19 profit in FY 2021).

All figures shown in the chart above are for the trailing 12 month (TTM) period

LEPU ScienTech Medical Technology (Shanghai)'s share price is broadly unchanged from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We have a graphic representation of LEPU ScienTech Medical Technology (Shanghai)'s balance sheet and an in-depth analysis of the company's financial position.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.